The tuberculosis vaccine has been around for nearly 100 years, but isn’t predictably effective against the deadly disease as currently administered. In the new study, Flynn and a large team of Pitt researchers, in collaboration with scientists from the National Institute of Allergy and Infectious Disease, found that giving the vaccine intravenously, instead of injecting it directly into the skin, increased its effectiveness substantially.
Co-director, JoAnne Flynn, published a groundbreaking study about TB in Nature
January 1, 2020
Wednesday, January 1, 2020